Transplant Patients' vaccine hurdle: could lowering immune drugs be the key?
NCT ID NCT05060991
First seen Apr 14, 2026 · Last updated May 22, 2026 · Updated 6 times
Summary
This study looked at 14 kidney transplant recipients whose immune systems are suppressed to prevent organ rejection. Because of this suppression, standard COVID-19 vaccines often don't work well for them. Researchers tested whether temporarily reducing their immunosuppressive medication before a third vaccine dose could improve their antibody response, while carefully monitoring for organ rejection or other safety issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of California, Davis
Sacramento, California, 95817, United States
Conditions
Explore the condition pages connected to this study.